Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Operational Update

16 Apr 2019 07:00

RNS Number : 2674W
Galliford Try PLC
16 April 2019
 

GALLIFORD TRY PLC

OPERATIONAL UPDATE

Galliford Try plc, the housebuilding, regeneration and construction group, announces that it is undertaking a strategic review of its Construction business.

The review will reduce the size of the Construction business, focusing on its key strengths in markets and sectors with sustainable prospects for profitability and growth, where we have a track record of success.

The review includes an assessment of operational progress and contract positions throughout the Construction business. The Board anticipates that this review will result in reduced profitability in the current year reflecting a reassessment of positions in legacy and some current contracts and the effect of some recent adverse settlements, as well as the costs of the restructure. The single largest element relates to the Queensferry Crossing joint venture, which has recently increased its estimated final costs on the project. With regard to the claim in respect of the completed Aberdeen Western Peripheral Route, and the previously disclosed £38m work in progress balance in respect of three contracts for a single client, our position is unchanged.

The Board expects that the outcome of this assessment will reduce the Group's full year post-exceptional profit before tax by £30m-£40m below the current consensus analysts' forecast1. The majority of our construction businesses continue to perform well, and these adjustments are not expected to have a significant impact on the Group's previous guidance on average net debt for the year.

The Board anticipates finalising its conclusions in the next few weeks and will share the detail of the review of the Construction business along with a further update on Group trading in its scheduled statement on 21 May 2019. 

This announcement contains inside information for the purposes of article 7 of EU Regulation 596/2014. The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel and Company Secretary.

 

For further enquiries:

Galliford Try

Graham Prothero, Chief Executive

Andrew Duxbury, Finance Director

Kevin Corbett, General Counsel & Company Secretary

 

01895 855001

Tulchan Communications

James Macey White, Martin Pengelley,

Elizabeth Snow

020 7353 4200

 

Notes to editors:

1. The mean of publicly available analysts' forecasts for profit before tax after taking into account exceptional items for the year ending 30 June 2019 is £156m based on company compiled consensus as at 15 April 2019.

2. Galliford Try plc is a leading UK housebuilding, regeneration and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2018, the Group generated revenue of £3.1bn.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDMMGMDRKMGLZM
Date   Source Headline
23rd Oct 202410:00 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 202411:30 amRNSAnnual Financial Report
16th Oct 20241:00 pmRNSDirector/PDMR Shareholding
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 202410:30 amRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20243:50 pmRNSDirector/PDMR Shareholding
8th Oct 20243:45 pmRNSDirector/PDMR Shareholding
8th Oct 20243:45 pmRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20245:25 pmRNSDirector/PDMR Shareholding
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:02 amRNSLaunch of Share Buyback Programme
3rd Oct 20247:00 amRNSFinal Results
30th Sep 20243:00 pmRNSTotal Voting Rights
24th Sep 20247:00 amRNSContract
23rd Sep 20247:00 amRNSContract
20th Sep 20248:44 amRNSNotification of Full Year Results
16th Sep 20247:01 amRNS2024 Full Year Results: Revised Publication Date
2nd Sep 20242:30 pmRNSDirector Declaration
2nd Sep 202410:30 amRNSTotal Voting Rights
27th Aug 20244:14 pmRNSBlock listing Interim Review
16th Aug 20249:30 amRNSContract
31st Jul 20244:00 pmRNSTotal Voting Rights
24th Jul 202410:30 amRNSDirector Declaration
23rd Jul 20247:00 amRNSContract
11th Jul 20247:00 amRNSTrading Statement
28th Jun 202411:00 amRNSTotal Voting Rights
13th Jun 20247:00 amRNSContract
31st May 20244:00 pmRNSTotal Voting Rights
31st May 20247:00 amRNSContract
23rd May 20247:00 amRNSCapital Markets Event
30th Apr 20244:00 pmRNSTotal Voting Rights
23rd Apr 20244:00 pmRNSDirector/PDMR Shareholding
10th Apr 20245:00 pmRNSHolding(s) in Company
5th Apr 202411:00 amRNSTotal Voting Rights
28th Mar 20247:00 amRNSDirectorate Change
8th Mar 20244:00 pmRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSHalf-year Report
4th Mar 20244:00 pmRNSTotal Voting Rights
1st Mar 20247:00 amRNSDirectorate Change
26th Feb 20246:03 pmRNSBlock listing Interim Review
22nd Feb 20247:00 amRNSContract
17th Jan 20247:00 amRNSTrading Statement
30th Nov 20234:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.